Company intelligence / Profile preview

ProterixBio

Billerica, Massachusetts, United States

Ownership: Private
Employees: ~26
Development stage: Other

Overview

ProterixBio has developed and validated several pulmonary and inflammatory biomarker assays, leveraging their ViBE technology platform to enable clinical diagnostics for chronic diseases with a focus on pulmonary indications. Comprehensive clinical data not disclosed, but company is commercial-stage for diagnostics.

Therapeutic areas: Pulmonology
Modalities: ProteinBiologicDevice
Industry: Protein Biomarker Diagnostics

Partnerships

Weill Cornell Medical CollegeUniversity of Illinois ChicagoBoston Children's HospitalImperial College LondonBiopharma collaborations for pulmonary disorders

Beyond the preview

Go deeper on ProterixBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProterixBio.

Explore the full profile